# Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?

> **NCT01865825** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 20 (actual)

## Conditions studied

- Erosive Esophagitis

## Interventions

- **RADIATION:** Esophageal Barium Xray

## Key facts

- **NCT ID:** NCT01865825
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01865825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01865825, "Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01865825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*